RJA
DNLI icon

Raymond James & Associates’s Denali Therapeutics DNLI Stock Holding History

Raymond James & Associates’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,894
Closed -$204K – 3854
2023
Q3 		$204K Sell
9,894
-137
-1% -$3.48K ﹤0.01% 3443
2023
Q2 		$296K Sell
10,031
-1,376
-12% -$38.7K ﹤0.01% 3267
2023
Q1 		$263K Buy
11,407
+1,490
+15% +$41K ﹤0.01% 3325
2022
Q4 		$276K Buy
+9,917
New +$295K ﹤0.01% 3271
2022
Q1 		– Sell
-4,926
Closed -$220K – 4152
2021
Q4 		$220K Sell
4,926
-1,245
-20% -$59K ﹤0.01% 3642
2021
Q3 		$311K Sell
6,171
-218
-3% -$12.3K ﹤0.01% 3382
2021
Q2 		$501K Sell
6,389
-1,096
-15% -$67.8K ﹤0.01% 3083
2021
Q1 		$427K Sell
7,485
-47
-0.6% -$3.15K ﹤0.01% 3131
2020
Q4 		$631K Buy
+7,532
New +$455K ﹤0.01% 2654

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return